期刊文献+
共找到219,984篇文章
< 1 2 250 >
每页显示 20 50 100
新质生产力发展视阈下的会计盈余披露改进研究——基于CAS盈余与Non-CAS盈余功用的实证检验
1
作者 王霞 李泰珉 吴佳琪 《上海财经大学学报(哲学社会科学版)》 北大核心 2025年第2期50-63,共14页
新质生产力是当下我国经济高质量发展的重要动力。会计盈余信息作为利益相关者进行判断和决策的依据,是促进要素有序流动、引导资源高效配置的重要手段,充分有效的会计盈余信息披露对于发展新质生产力至关重要。但是,随着企业在科技创... 新质生产力是当下我国经济高质量发展的重要动力。会计盈余信息作为利益相关者进行判断和决策的依据,是促进要素有序流动、引导资源高效配置的重要手段,充分有效的会计盈余信息披露对于发展新质生产力至关重要。但是,随着企业在科技创新推动下不断发展新业态、新产业,传统的会计准则已经滞后于复杂的经济形势。文章通过实证研究发现,现行会计准则下的盈余(CAS盈余)无法包含新质生产力发展程度高的企业未来业绩改善的信息增量,其持续性和预测性下降。文章在CAS盈余的基础上,对企业发展新质生产力投入的临时性项目进行调整,设计了Non-CAS盈余。检验发现,对于新质生产力发展水平较高的企业,Non-CAS盈余具有更好的持续性和预测性。上述影响对创业板、科创板等非主板市场企业更为明显。在股票定价方面,Non-CAS盈余同样发挥了定价作用。因此,有必要改进现行的会计盈余披露制度,允许上市企业自愿披露Non-CAS盈余,以满足会计信息更好地服务大力发展新质生产力的时代要求。 展开更多
关键词 新质生产力 CAS盈余 non-CAS盈余 盈余持续性 盈余预测性
原文传递
Application and Research Advancement of Antibody-Conjugated Drugs in Non-Small Cell Lung Cancer
2
作者 Binting Huang Kaifang Li +2 位作者 Xiangsheng Wu Fuyi Zhang Yepeng Li 《Journal of Biosciences and Medicines》 2025年第1期145-162,共18页
Lung cancer is one of the malignant tumor diseases with high morbidity and high mortality in the world. Non-small cell lung cancer (NSCLC) is the most common pathological type of lung cancer. Currently, chemotherapy, ... Lung cancer is one of the malignant tumor diseases with high morbidity and high mortality in the world. Non-small cell lung cancer (NSCLC) is the most common pathological type of lung cancer. Currently, chemotherapy, targeted therapy, immunotherapy or combination therapy is the main treatment for NSCLC, but it is still inevitably faced with the challenges of acquired drug resistance and tumor progression. The birth of antibody conjugator provides a new choice for its treatment. Antibody conjugator is a new type of biotherapeutic drug which is connected by monoclonal antibody via linker and cytotoxic drug. It has the characteristics of precision, high efficiency and low toxicity, etc. In recent years, its research and development and clinical trials have been endless. It shows that this new type of drug has great potential in the field of tumor therapy. In this paper, the structural characteristics, mechanism of action, current application, research achievements, challenges, countermeasures and development of ADC in NSCLC treatment are reviewed. 展开更多
关键词 non-Small Cell Lung Cancer Antibody Coupling Drugs Combination Therapy Adverse Reaction
暂未订购
Efficacy and Safety of Janus Kinase Inhibitors (JAKi) versus Interleukin 17 Inhibitors (IL-17i) in the Treatment of Active Non-Radiographic Axial Spondyloarthritis (nr-ax SpA), a Comparative Systematized Review
3
作者 Yasir Mohammed Rizwan Rajak 《Open Journal of Rheumatology and Autoimmune Diseases》 2025年第1期1-21,共21页
Background: Non-radiographic axial spondyloarthritis is a progressive and disabling inflammatory disease affecting young adults, with limited treatment options. TNFi are more efficacious than JAKi and IL1-7i in nr-ax ... Background: Non-radiographic axial spondyloarthritis is a progressive and disabling inflammatory disease affecting young adults, with limited treatment options. TNFi are more efficacious than JAKi and IL1-7i in nr-ax SPA and it has a well-known safety profile over a longer duration. Recently, many IL-17i and JAKi were approved for the treatment of nr-ax SPA;however, data comparing IL1-7i and JAKi in terms of efficacy and safety is lacking. This systematized review aimed to compare the existing efficacy and safety data of JAKi vs IL-17i in the treatment of patients with nr-ax SPA. Methods: A systematic literature search was performed using relevant keywords in many databases. According to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA, 2020), relevant articles were included and evaluated in this review. Efficacy and safety data were collected, analyzed and compared through week 52. The first check was done by the end of week 14 and week 16 for upadacitinib and IL-17i respectively. Results: Data from four RCTs evaluating upadacitinib, secukinumab, ixekizumab, and bimekizumab comprising 1425 patients were analyzed. Overall, a comparable efficacy and safety profile were observed across different treatment arms through week 52;however, non-significant variations were encountered in some outcome measures. The primary endpoint among these RCTs (ASAS40 response rate) was met and it was higher in patients treated with bimekizumab 160 mg sc Q 4 weeks in TNFi non responders (48%) and lowest in ixekizumab 80 mg sc Q 4 weeks treated patients, (35%) (p Conclusion: The above-mentioned three IL-17i and the only one JAKi demonstrated comparable safety and efficacy profiles with some minor variations. A head-to-head trial comparing the effectiveness and safety characteristics of JAKi vs IL-17i may be needed in patients with active nr-ax SpA. 展开更多
关键词 non-Radiographic Axial Spondyloarthritis nr-ax SPA JAKi Interleukin 17 Inhibitors IL-17i Janus Kinase Inhibitors
暂未订购
Countability of Infinite Paths in the Infinity Tree: Proof of the Continuum Hypothesis in a Non-Cantorian Infinity Theory
4
作者 Philip C. Jackson 《Advances in Pure Mathematics》 2025年第1期73-90,共18页
A previous paper showed that the real numbers between 0 and 1 could be represented by an infinite tree structure, called the ‘infinity tree’, which contains only a countably infinite number of nodes and arcs. This p... A previous paper showed that the real numbers between 0 and 1 could be represented by an infinite tree structure, called the ‘infinity tree’, which contains only a countably infinite number of nodes and arcs. This paper discusses how a finite-state Turing machine could, in a countably infinite number of state transitions, write all the infinite paths in the infinity tree to a countably infinite tape. Hence it is argued that the real numbers in the interval [0, 1] are countably infinite in a non-Cantorian theory of infinity based on Turing machines using countably infinite space and time. In this theory, Cantor’s Continuum Hypothesis can also be proved. And in this theory, it follows that the power set of the natural numbers P(ℕ) is countably infinite, which contradicts the claim of Cantor’s Theorem for the natural numbers. However, this paper does not claim there is an error in Cantor’s arguments that [0, 1] is uncountably infinite. Rather, this paper considers the situation as a paradox, resulting from different choices about how to represent and count the continuum of real numbers. 展开更多
关键词 INFINITY Countable UNCOUNTABLE Diagonalization Real Numbers Infinity Tree Continuum Hypothesis Turing Machine Infinite Time Turing Machine non-Cantorian
在线阅读 下载PDF
LQR Discrete Time Control of a Buck Converter Using a Non-Minimal State Space Representation
5
作者 Richard Tymerski 《Journal of Power and Energy Engineering》 2025年第1期32-46,共15页
This paper presents an advanced control strategy for DC-DC buck converters utilizing Non-Minimal State Space (NMSS) representation combined with Proportional-Integral-Plus (PIP) control, optimized through Linear Quadr... This paper presents an advanced control strategy for DC-DC buck converters utilizing Non-Minimal State Space (NMSS) representation combined with Proportional-Integral-Plus (PIP) control, optimized through Linear Quadratic Regulator (LQR) design. The proposed approach leverages NMSS to eliminate the need for state observers, enhancing robustness against model mismatch and improving overall system performance. The PIP controller extends traditional PI control by incorporating additional dynamic feedback. Experimental results demonstrate that the NMSS-PIP-LQR controlled buck converter achieves excellent dynamic performance. The design procedure is fully documented, and microcontroller implementation issues are discussed. 展开更多
关键词 DC-DC Buck Converter non-Minimal State Space (NMSS) Proportional-Integral-Plus (PIP) Control Linear Quadratic Regulator (LQR) F28069M Microcontroller
在线阅读 下载PDF
血清non-HDL-C/HDL-C、血浆致动脉粥样硬化指数与慢性肾病发病风险的前瞻性队列研究
6
作者 游金龙 王雪 +7 位作者 唐靖 李秀茜 王瑞 姜敏 张文君 白亚娜 王敏珍 郑山 《中华疾病控制杂志》 北大核心 2025年第9期1096-1103,共8页
目的评估血清非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值(non-high density lipoprotein cholesterol/high density lipoprotein cholesterol,NHHR)、血浆致动脉粥样硬化指数(atherogenic index of plasma,AIP)与慢性肾病(chronic k... 目的评估血清非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值(non-high density lipoprotein cholesterol/high density lipoprotein cholesterol,NHHR)、血浆致动脉粥样硬化指数(atherogenic index of plasma,AIP)与慢性肾病(chronic kidney disease,CKD)发病风险的关系,为CKD的防治提供依据。方法以金昌队列中25377名未患CKD的参与者作为研究对象,采用Cox比例风险回归模型、限制性立方样条分别评估NHHR和AIP对CKD的发病风险及剂量-反应关系,并进行亚组分析。采用受试者工作特征曲线评估NHHR和AIP对CKD发病风险的预测能力。结果经过平均4.77年的随访调查后,新发CKD患者有1213例,发病密度为10.03/1000人年。调整混杂因素后,相较于Q1组,Q4组人群中NHHR和AIP的CKD发病风险比分别为1.270(95%CI:1.066~1.512)和1.294(95%CI:1.081~1.548),且均存在一定的剂量-反应关系(均P<0.05)。NHHR和AIP预测CKD的AUC值分别为0.750(95%CI:0.736~0.764)和0.735(95%CI:0.721~0.749)。亚组分析发现,吸烟和糖尿病与NHHR、糖尿病和AIP间存在交互作用(均P<0.05)。结论NHHR和AIP是CKD发病的独立危险因素,并对CKD发病风险有一定的预测能力。 展开更多
关键词 非高密度脂蛋白胆固醇 高密度脂蛋白胆固醇 血浆致动脉粥样硬化指数 血脂代谢 慢性肾病 前瞻性队列研究
原文传递
老年急性缺血性脑卒中患者PIV、non-HDL-C、IL谱特征与神经功能损伤严重程度的相关性分析 被引量:2
7
作者 张海涛 葛仁美 刘小江 《中风与神经疾病杂志》 2025年第4期352-356,共5页
目的探究老年急性缺血性脑卒中患者泛免疫炎症值(PIV)、非高密度脂蛋白胆固醇(non-HDL-C)、白细胞介素(IL)谱特征与神经功能损伤严重程度的相关性分析。方法回顾性分析2019年10月—2024年10月在海安市人民医院住院治疗的158例老年急性... 目的探究老年急性缺血性脑卒中患者泛免疫炎症值(PIV)、非高密度脂蛋白胆固醇(non-HDL-C)、白细胞介素(IL)谱特征与神经功能损伤严重程度的相关性分析。方法回顾性分析2019年10月—2024年10月在海安市人民医院住院治疗的158例老年急性缺血性脑卒中患者,根据患者合并神经功能损伤严重程度分为非重度神经功能损伤组(112例)和重度神经功能损伤组(46例)。对比两组间一般临床资料、PIV、non-HDL-C、IL的差异。采用Logistic回归分析老年急性缺血性脑卒中患者重度神经功能损伤的危险因素,通过受试者工作特征曲线(ROC)评价各危险因素的预测价值。结果与非重度神经功能损伤组比较,重度神经功能损伤组患者HDL-C水平显著较低、non-HDL-C、PIV、IL-1β、IL-6、IL-8水平显著较高(P<0.05);多因素Logistic回归分析表明HDL-C、non-HDL-C、PIV、IL-1β、IL-6、IL-8均是老年急性缺血性脑卒中患者重度神经功能损伤的影响因素(P<0.05);ROC曲线表明HDL-C、non-HDL-C、PIV、IL-1β、IL-6、IL-8联合预测老年急性缺血性脑卒中患者重度神经功能损伤的效能高于各因素独立预测效能(Z=4.234、4.411、3.897、4.240、4.001、4.420,P均<0.001)。结论PIV、non-HDL-C、促炎性IL水平较高的老年急性缺血性脑卒中患者神经功能损伤程度较严重。 展开更多
关键词 老年 缺血性脑卒中 泛免疫炎症值 非高密度脂蛋白胆固醇 白细胞介素
暂未订购
Non-HDL-C/HDL-C比值与糖代谢异常人群全因死亡风险关系:基于CHARLS数据库
8
作者 张洁 方奎 陈红艳 《医学新知》 2025年第8期878-884,共7页
目的探讨非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值(NHHR)与糖代谢异常人群全因死亡风险的关系,为糖代谢异常患者的血脂管理提供科学依据。方法基于中国健康与养老追踪调查2011—2018年数据,以糖代谢异常人群(包括糖尿病前期和糖... 目的探讨非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值(NHHR)与糖代谢异常人群全因死亡风险的关系,为糖代谢异常患者的血脂管理提供科学依据。方法基于中国健康与养老追踪调查2011—2018年数据,以糖代谢异常人群(包括糖尿病前期和糖尿病患者)为研究对象,通过限制性立方样条和Cox比例风险回归模型分析NHHR与糖代谢异常人群全因死亡风险的关系。结果共纳入6300名研究对象,7年随访期间共有685人死亡。NHHR与糖代谢异常人群全因死亡风险存在显著的U形非线性关系,拐点值为3.03(非线性P=0.006)。当NHHR<3.03时,NHHR每增加一个单位,全因死亡风险降低21%[HR=0.79,95%CI(0.65,0.95)];当NHHR≥3.03时,每增加一个单位,全因死亡风险增加5%[HR=1.05,95%CI(1.01,1.08)]。对NHHR三分位数分层分析显示,中间三分位数组的全因死亡风险最低,与中间三分位数组相比,低三分位数组[HR=1.26,95%CI(1.05,1.52)]和高三分位数组[HR=1.23,95%CI(1.01,1.49)]的死亡风险均显著增加。结论NHHR与糖代谢异常人群全因死亡风险之间存在显著的U形非线性关系。 展开更多
关键词 非高密度脂蛋白胆固醇 高密度脂蛋白胆固醇 NHHR 糖代谢异常 血脂异常 全因死亡风险 队列研究
暂未订购
PE患者妊娠结局危险因素分析及non-HDL-C/HDL-C比值的预测效能
9
作者 任艳华 王月 +4 位作者 徐闻铂 王新彦 刘欣悦 刘春稳 孙志敏 《中国计划生育学杂志》 2025年第2期414-418,共5页
目的:分析子痫前期(PE)患者孕中期非高密度脂蛋白胆固醇/高密度脂蛋白胆固醇比值(non-HDL-C/HDL-C)与不良妊娠结局关系及预测价值。方法:收集2022年6月-2023年12月本院产前检查并分娩的PE患者102例临床资料,根据是否出现不良妊娠结局分... 目的:分析子痫前期(PE)患者孕中期非高密度脂蛋白胆固醇/高密度脂蛋白胆固醇比值(non-HDL-C/HDL-C)与不良妊娠结局关系及预测价值。方法:收集2022年6月-2023年12月本院产前检查并分娩的PE患者102例临床资料,根据是否出现不良妊娠结局分为不良妊娠组(n=38)与良好妊娠组(n=64),收集患者临床资料,计算non-HDL-C值、non-HDL-C/HDL-C值;采用多因素logistic回归分析探讨PE患者不良妊娠结局影响因素;采用受试者工作特性(ROC)曲线分析non-HDL-C/HDL-C对PE患者不良妊娠结局的预测价值。结果:不良妊娠组non-HDL-C(5.91±0.23 mmol/L)、non-HDL-C/HDL-C(3.79±0.25)均高于良好妊娠组(4.63±0.27 mmol/L、2.71±0.13)(均P<0.05)。多因素回归分析,24h尿蛋白升高、血小板计数降低、non-HDL-C升高、non-HDL-C/HDL-C升高是PE患者不良妊娠结局危险因素(P<0.05);non-HDL-C、non-HDL-C/HDL-C预测PE患者不良妊娠结局的曲线下面积分别为0.793、0.925。结论:24h尿蛋白升高、血小板计数降低、non-HDL-C升高、non-HDL-C/HDL-C升高是PE患者不良妊娠结局危险因素,且non-HDL-C/HDL-C预测PE患者不良妊娠结局价值较好。 展开更多
关键词 子痫前期 非高密度脂蛋白胆固醇/高密度脂蛋白胆固醇 不良妊娠结局 预测价值 危险因素
暂未订购
Reversible solid-liquid conversion enabled by self-capture effect for stable non-flow zinc-bromine batteries 被引量:1
10
作者 Xixi Zhang Xiaoke Wang +7 位作者 Guangmeng Qu Tairan Wang Xiliang Zhao Jun Fan Cuiping Han Xijin Xu Chunyi Zhi Hongfei Li 《Green Energy & Environment》 SCIE EI CAS CSCD 2024年第6期1035-1044,共10页
Non-flow aqueous zinc-bromine batteries without auxiliary components(e.g.,pumps,pipes,storage tanks)and ion-selective membranes represent a cost-effective and promising technology for large-scale energy storage.Unfort... Non-flow aqueous zinc-bromine batteries without auxiliary components(e.g.,pumps,pipes,storage tanks)and ion-selective membranes represent a cost-effective and promising technology for large-scale energy storage.Unfortunately,they generally suffer from serious diffusion and shuttle of polybromide(Br^(-),Br^(3-))due to the weak physical adsorption between soluble polybromide and host carbon materials,which results in low energy efficiency and poor cycling stability.Here,we develop a novel self-capture organic bromine material(1,10-bis[3-(trimethylammonio)propyl]-4,4'-bipyridinium bromine,NVBr4)to successfully realize reversible solid complexation of bromide components for stable non-flow zinc-bromine battery applications.The quaternary ammonium groups(NV^(4+)ions)can effectively capture the soluble polybromide species based on strong chemical interaction and realize reversible solid complexation confined within the porous electrodes,which transforms the conventional“liquid-liquid”conversion of soluble bromide components into“liquid-solid”model and effectively suppresses the shuttle effect.Thereby,the developed non-flow zinc-bromide battery provides an outstanding voltage platform at 1.7 V with a notable specific capacity of 325 mAh g^(-1)NVBr4(1 A g^(-1)),excellent rate capability(200 mAh g^(-1)NVBr4 at 20 A g^(-1)),outstanding energy density of 469.6 Wh kg^(-1)and super-stable cycle life(20,000 cycles with 100%Coulombic efficiency),which outperforms most of reported zinc-halogen batteries.Further mechanism analysis and DFT calculations demonstrate that the chemical interaction of quaternary ammonium groups and bromide species is the main reason for suppressing the shuttle effect.The developed strategy can be extended to other halogen batteries to obtain stable charge storage. 展开更多
关键词 Solid-liquid conversion Self-capture non-flow zinc-bromine batteries Quaternary ammonium
在线阅读 下载PDF
Research Progress on Different Endoscopic Hemostatic Regimens for the Treatment of Acute Non-Varicose Upper Gastrointestinal Bleeding
11
作者 Mengzhen Xu Ping Lu 《Journal of Biosciences and Medicines》 2024年第11期70-79,共10页
Acute upper gastrointestinal hemorrhage is a highly prevalent clinical condition, with the majority of cases representing acute non-variceal upper gastrointestinal hemorrhage. With the advancement of modern medicine, ... Acute upper gastrointestinal hemorrhage is a highly prevalent clinical condition, with the majority of cases representing acute non-variceal upper gastrointestinal hemorrhage. With the advancement of modern medicine, endoscopy has become an indispensable tool in the diagnosis and treatment of various diseases. In order to achieve optimal results in the endoscopic treatment of non-variceal upper gastrointestinal bleeding, it is essential to make an accurate and timely diagnosis and select the most appropriate treatment method. This article introduces the definition of acute non-variceal upper gastrointestinal bleeding (ANVUGIB) and the importance of endoscopic treatment for this disease. It then presents an overview of various assessment systems for ANVUGIB and an overview of endoscopic advances in thermal coagulation, mechanical hemostasis, and topical pharmacological injection hemostasis for three aspects of ANVUGIB-related bleeding. In particular, this article discusses the therapeutic efficacy and safety of different treatment options for non-variceal upper gastrointestinal bleeding, as well as the advantages and limitations of these treatment options in managing this disease. 展开更多
关键词 ENDOSCOPY non-VARICEAL Upper Gastrointestinal Bleeding HEMOSTASIS
暂未订购
Progress in the Use of Glucocorticoids and Biological Agents in Non-Infectious Uveitis
12
作者 Yuxuan Liu Xunyu Zou +1 位作者 Shizhou Cheng Zuhai Zhang 《Journal of Biosciences and Medicines》 2024年第2期138-155,共18页
One of the main immune-mediated diseases that lead to avoidable blindness is non-infectious uveitis. Glucocorticoids are the first-line therapy choice for noninfectious uveitis;however, biologics are also showing prom... One of the main immune-mediated diseases that lead to avoidable blindness is non-infectious uveitis. Glucocorticoids are the first-line therapy choice for noninfectious uveitis;however, biologics are also showing promise in the management of this condition. The description of glucocorticoid and biologic usage in non-infectious uveitis is the main topic of this paper. 展开更多
关键词 non-Infectious Uveitis GLUCOCORTICOIDS Biological Agents
暂未订购
Investigating Non-Compliance with COVID-19 Vaccination through Hesitancy, Refusal, and Access Limitation: A Community-Based Survey from the Democratic Republic of the Congo
13
作者 Nestor Kalala-Tshituka Alain Cimuanga-Mukanya +5 位作者 Alain Yamba Mukendi Faustin Ndjibu Mpoji Ghislain Disashi-Tumba Joris Losimba Likwela Nadine Kayiba Kalenda Evariste Tshibangu-Kabamba 《Journal of Biosciences and Medicines》 2024年第9期280-306,共27页
Introduction: Vaccination plays a pivotal role in mitigating the repercussions of the COVID-19 pandemic. However, vaccination campaigns encounter obstacles, especially in developing countries like the Democratic Repub... Introduction: Vaccination plays a pivotal role in mitigating the repercussions of the COVID-19 pandemic. However, vaccination campaigns encounter obstacles, especially in developing countries like the Democratic Republic of the Congo (DRC). This study aimed at investigating the roles of vaccine hesitancy, refusal, and access barriers, while identifying individual-level factors associated with non-vaccination in Mbujimayi, DRC. Methods: A community-based cross-sectional survey was conducted in three health districts and included 1496 residents. Attitudes and behaviors related to seeking COVID-19 vaccination were assessed using a standardized questionnaire. Hierarchical logistic regression modeling was used to assess factors potentially affecting non-compliance with vaccination. Results: Among participants (median age = 33, IQR = 23.3, M/F sex ratio = 0.7), 60% displayed misconceptions about COVID-19 or its vaccine, while only 35.2% perceived COVID-19 as a significant health threat. Vaccination coverage was estimated at 49.1% (95% CI: 47.5;52.6), with 71.8% of vaccinated individuals having received one dose. Among the unvaccinated individuals, 50.9% expressed no intention to be vaccinated in the future, citing hesitation (30.4%) or refusal (39.6%) mainly due to side effects or distrust of vaccines. Conversely, 32.7% of the unvaccinated persons expressed access barriers despite willingness to be vaccinated. Misconceptions about COVID-19 and its vaccines were the main drivers of vaccination non-compliance. Conclusion: These findings demonstrate significant vaccine non-compliance driven by hesitancy, refusal, and access barriers. Strategies to enhance vaccination coverage and pandemic preparedness should address misconceptions, sociodemographic barriers, and geographic disparities. 展开更多
关键词 COVID-19 VACCINATION non-Observance Community Democratic Republic of the Congo
在线阅读 下载PDF
The Interventional Capacity of Community Health Volunteers for Screening and Linkages of Non-Communicable Diseases in Nyeri County, Kenya
14
作者 Kenneth Mugambi Jackline Nyaberi Elizabeth Echoka 《Open Journal of Preventive Medicine》 2024年第4期61-78,共18页
Non-communicable diseases (NCDs) account for 63% of mortalities. Approximately 80% of these NCD-related deaths occur in LMICs. A quasi-experimental study utilizing a non-equivalent pre-and post-test was conducted from... Non-communicable diseases (NCDs) account for 63% of mortalities. Approximately 80% of these NCD-related deaths occur in LMICs. A quasi-experimental study utilizing a non-equivalent pre-and post-test was conducted from May 2022 to March 2023 with 370 study participants. Multistage cluster and random sampling were used to select ten community units, and therefore, 150 CHVs were chosen for the control unit, and 150 were used to form the interventional group. Data was collected from the KOBO app. Six (6) homogenous FGDs comprised ten members, and 10 KII were conducted across study sites. Quantitative data was analyzed using SPSS version 28.0, and qualitative data was audio-recorded, transcribed, and analyzed via N-Vivo 12. The study shows that 59.3% of respondents have minimal information, and 92.7% (n = 139) have no clear understanding of NCDs, with a pre-intervention capacity of 48.8%. Independent sample t-test showed a significant difference in capacity from a pre-intervention average of 48.75 (SD ± 5.7)%, which increased to 68.28 (SD ± 7.6)%, p < 0.001. A well-designed community interventional model plays a pivotal role in grassroots healthcare delivery but requires optimization for NCD management. 展开更多
关键词 INTERVENTION Community Health Volunteers non-Communicable Disease SCREENING Linkages
在线阅读 下载PDF
Roles of Community Pharmacists in Screening and Disseminating of Information about Non-Steroidal Anti-Inflammatory Drugs Risks: Implications for Drug Safety Assessment
15
作者 Martin Kampamba Progress Mulenga +8 位作者 Steward Mudenda Billy Chabalenge Jenipher Zulu Tadius Chimombe Webrod Mufwambi Mashebe Innocent Ngula Audrey Hamachila Jimmy Hangoma Christabel Nang’andu Hikaambo 《Pharmacology & Pharmacy》 2024年第4期129-145,共17页
Background: The increasing use of non-steroidal anti-inflammatory drugs (NSAIDs) both on prescription and over the counter raises a major global health concern because of the risks associated with their use if no prop... Background: The increasing use of non-steroidal anti-inflammatory drugs (NSAIDs) both on prescription and over the counter raises a major global health concern because of the risks associated with their use if no proper guidance is given by the health care provider. This study assessed the roles of community pharmacists in screening and disseminating information about the risks associated with NSAID use in Zambia. Methodology: This was a national cross-sectional study in which a structured self-administered questionnaire was administered to 245 registered community pharmacists in Zambia. Stata/BE, version 15.1 (Stata Corporation, College Station, Texas, USA) and multivariate logistic regression model was used to determine factors associated with information dissemination about ADRs of NS-NSAIDs. Results: 231 of the 245 distributed questionnaires were returned giving a response rate of 94.3%. All (100%) participating community pharmacists claimed to have practiced dispensing NSAIDs. However, only 26 (11.0%) and 71 (30.8%) regularly screened for risk factor of selective COX-2 NSAIDS (SC2-NSAIDS) and non-selective NSAIDS (NS-NSAIDs) respectively. Information dissemination on adverse drug reactions (ADRs) of SC2-NSAIDS was regularly provided by only 22 (9.5%) of pharmacists while that of NS-NSAIDs was regularly provided by 49 (21.2%). In the multivariate logistic regression model, being the owner of a pharmacy (AOR: 5.4, CI: 1.84 - 16.4) was significantly associated with information dissemination about ADRs of NS-NSAIDs while an hour increase in the working hours per day (AOR: 0.9, CI: 0.64 - 0.95) was associated with less likelihood of information dissemination. Conclusion: Pharmacists working in community pharmacies in Zambia did not regularly screen and disseminate information about the risks associated with NSAID use. Therefore, pharmacists should be able to screen and monitor patients at risk and be aware of the majority of risk factors while dispensing NSAIDs to minimize the associated complications. 展开更多
关键词 Community Pharmacists non-Steroidal Anti-Inflammatory Drug Risk SCREENING
暂未订购
Primary Non-Hodgkin’s Malignant Lymphoma of the Uterus at the Reference Hospital of Maradi/Niger: A Case Report
16
作者 Moustapha Elhadji-Chefou Badé Malam-Abdou +5 位作者 Amadou Djibrilla-Almoustapha Maman Brah Moustapha Oumou Kimso Ibrahim Timi Liman Elhadji Ali Issa Abdou Amadou Borges Moreno Yuribet 《Open Journal of Blood Diseases》 2024年第2期43-46,共4页
Malignant non-Hodgkins lymphoma (MHNL) of the uterus is uncommon. We report a case diagnosed on the basis of histologic and immunohistochemical studies of a hysterectomy specimen induced by a very painful pelvic mass ... Malignant non-Hodgkins lymphoma (MHNL) of the uterus is uncommon. We report a case diagnosed on the basis of histologic and immunohistochemical studies of a hysterectomy specimen induced by a very painful pelvic mass in a 50-year-old patient with no previous history of the disease. It was classified as Ann Arbor IV Bb after imaging, given the medullary infiltration and signs of clinical and biological evolutivity: the patient had received two courses of chemotherapy, CHOP protocol. She died 23 days after the second treatment due to a hypertensive crisis. 展开更多
关键词 Malignant non-Hodgkin’s Lymphoma UTERUS Referral Hospital Maradi/Niger
暂未订购
Assessment of Barriers and Challenges to the Screening and Linkages of Non-Communicable Diseases by Community Health Volunteers in Nyeri County, Kenya
17
作者 Kenneth Mugambi Jackline Nyaberi Elizabeth Echoka 《Open Journal of Preventive Medicine》 2024年第5期90-109,共20页
Non-communicable diseases (NCDs) are a significant global health challenge, contributing to 50% of worldwide morbidity and 63% of mortality. The burden is particularly substantial in low—and middle-income countries (... Non-communicable diseases (NCDs) are a significant global health challenge, contributing to 50% of worldwide morbidity and 63% of mortality. The burden is particularly substantial in low—and middle-income countries (LMICs), where 80% of NCD-related deaths occur. A quasi-experimental study addressed this challenge from May 2022 to March 2023. This study utilized a non-equivalent pre-and post-test design, with 300 participants in the quantitative and 70 in the qualitative. The study employed multistage cluster and random sampling to select ten community units, resulting in 150 community health volunteers (CHVs) in the control unit and 150 in the intervention group. Data collection was facilitated through the KOBO app. Qualitative data analysis involved six homogeneous focus group discussions (FGDs) and ten key informant interviews (KIIs), audio-recorded, transcribed, and analyzed using N-Vivo 12. Despite efforts to implement screening programs and improve linkages to care, significant barriers persist. This article reviews these barriers, drawing on current literature and empirical evidence. Key obstacles identified include limited awareness, inadequate healthcare infrastructure, cultural beliefs, financial constraints, fragmented healthcare systems, and challenges linking individuals to appropriate care services. The article explores strategies to overcome these barriers, emphasizing the importance of collaborative approaches involving stakeholders at various levels. Addressing these challenges aims to strengthen NCD screening and linkages to care, ultimately improving health outcomes for populations globally. Several recommendations emerge from the study’s findings and literature review. Raising awareness about NCDs and preventive measures is crucial and can be achieved through targeted health education campaigns and community outreach programs. Addressing healthcare infrastructure deficiencies, such as inadequate facilities and workforce shortages, is essential to ensure access to quality care. Cultural beliefs and practices also play a significant role in shaping health-seeking behavior. Engaging with local communities and incorporating cultural sensitivity into healthcare delivery can help bridge the gap between traditional beliefs and modern healthcare practices. Financial constraints pose a significant barrier to healthcare services, particularly in LMICs. Innovative financing mechanisms, such as health insurance schemes or subsidies, can help alleviate this burden and improve access to care. Furthermore, the fragmented nature of healthcare systems can hinder effective NCD management. Enhancing coordination and integration between primary care providers, specialists, and community health workers is essential to ensure seamless care delivery and patient follow-up. Finally, strengthening linkages between screening programs and care services is critical for the timely diagnosis and management of NCDs. This requires establishing robust referral systems and ensuring continuity of care for patients throughout their healthcare journey. In conclusion, addressing the multifaceted barriers to NCD screening and care linkage is essential for improving health outcomes globally. By implementing targeted interventions and fostering collaboration among stakeholders, progress can be made towards reducing the burden of NCDs and promoting population health. 展开更多
关键词 non-Communicable Diseases Barriers CHALLENGES Healthcare Infrastructure AWARENESS Cultural Beliefs Financial Constraints
在线阅读 下载PDF
Early Treatment Outcome of Humeral Shaft Fracture Non-Union in Adults: Comparative Study of Plating versus Interlocking Nailing
18
作者 Abdullallahi Bello Galadima Lukman Olalekan Ajiboye +1 位作者 Muhammad Nuhu Salihu Isha Nurudeen 《Health》 2024年第4期371-381,共11页
Background: Fractures of humeral shaft in adults are common injuries. Humeral shafts non-union either from late presentation after initial treatment by traditional bone setters or failed non-operative orthodox care is... Background: Fractures of humeral shaft in adults are common injuries. Humeral shafts non-union either from late presentation after initial treatment by traditional bone setters or failed non-operative orthodox care is a major problem in this part of the world. This non-union is a major treatment challenge with increased cost of care and morbidity in this part of the world. Humeral shaft non-union can be treated with locked intra-medullary nailing (LIMN) or dynamic compression plating (DCP). Study on comparison of these methods of fixation in this part of the world is scarce in literature search, hence the reason for this study. Objective: The objectives of this study are: (1) to compare early clinical outcome following fixation of humeral shaft fracture nonunion with DCP versus LIMN;(2) to compare the time of radiologic fracture union of DCP with LIMN;(3) to compare complications following fixation of humeral shaft fracture nonunion with DCP versus LIMN. Patients and Methods: This was a randomized control study done for 2 years in which fifty adult patients with humeral shaft non-union were recruited. The patients were grouped into 2 (P = DCP & N = LIMN). Forty five of the patients completed the follow up periods of the study and then analyzed. The P group had ORIF with DCP while the N group had ORIF with LIMN. Both groups had grafting with cancellous bones. Each patient was followed up for a period of 6 months at the time which radiographic union is expected. Any patient without clinical and/or radiographic evidence of union after six months of surgery was diagnosed as having recurrent non-union. The data generated was analyzed using SPSS Version 23. The results were presented in charts and tables. The paired t-test was used while considering p value Result: Forty five patients completed follow up. There was a male preponderance (4:1), right humerus predominated (3:2). Motor vehicular accidents were the commonest cause of the fractures (62%). Most non-union fractures occurred at the level of the middle 3<sup>rd</sup> of the humeral shaft (60%). Failed TBS treatment was the commonest indication for the osteosynthesis (71%). More patients had plating (53%) compared to 47% who had LIMN. Most patients (93.4%) had union between 3 to 6 months irrespective of fixation type with no significant statistical difference between the union rate of DCP and LIMN (p value 0.06) with similar functional outcome and complication rates irrespective of the type of fixation. Conclusion: This study showed that the success rates in term of fracture union, outcome functional grades and complication rates were not directly dependent on the types of the fixation: plating or locked intra-medullary nailing. 展开更多
关键词 Humeral Shaft non-UNION Dynamic Compression Plating Locked Intra-Medullary Nailing Early Treatment Outcome Early Outcome
暂未订购
Progress in the Study of Inflammatory Bowel Disease Patients with Primary Non-Responsiveness
19
作者 Yixue Liu Xiaoping Tan 《Journal of Biosciences and Medicines》 2024年第1期72-85,共14页
Inflammatory bowel disease (IBD) is a group of chronic, nonspecific intestinal inflammatory disorders characterized by localized and systemic inflammation. The use of biologic agents in the treatment of IBD patients i... Inflammatory bowel disease (IBD) is a group of chronic, nonspecific intestinal inflammatory disorders characterized by localized and systemic inflammation. The use of biologic agents in the treatment of IBD patients is widespread, and the occurrence of primary non-responsiveness during treatment is also significant. This review briefly summarizes the possible reasons for primary non-responsiveness in IBD patients, as well as predictive markers and current strategies to address it, providing a theoretical reference for early identification and management of IBD patients who do not respond to treatment. 展开更多
关键词 Inflammatory Bowel Disease Primary non-Responsiveness Anti-Tumor Necrosis Factor
暂未订购
Pang Fuwan Uses Yao Medicine to Observe the Therapeutic Effects on the Physical and Mental Symptoms of Patients with Advanced Non-Small Cell Lung Cancer
20
作者 Qiuxiang Luo Qiongping Liang Xiaoyan Luo 《Pharmacology & Pharmacy》 2024年第3期62-69,共8页
Objective: Investigate the efficacy and safety of Yao Medicine in the treatment of advanced non-small-cell lung carcinoma, and explore the best therapeutic measure for clinical benefit. Methods: From July 2020 to July... Objective: Investigate the efficacy and safety of Yao Medicine in the treatment of advanced non-small-cell lung carcinoma, and explore the best therapeutic measure for clinical benefit. Methods: From July 2020 to July 2022, 84 patients with advanced non-small-cell lung carcinoma were selected and randomly divided into the Observation Group and control group, and the control group was treated with routine Western medicine, with 42 cases in each group. The activity of daily living (ADL) was assessed before and after treatment, meanwhile, the self-rating depression scale (SDS) and self-rating anxiety SAS (SAS) were used to assess the improvement of a bad mood, and quality of life SF-36 was used to assess the quality of life, to judge the efficacy and safety. Results: The effective rate of observation group was 91.67%. The effective rate of the control group was 76.19%. The effective rate of the observation group was significantly higher than that of the control group (P 0.05). There were no significant differences in the scores of SDS, SAS and quality of life between the two groups before treatment (P > 0.05), and after treatment, the scores of SDS, SAS and quality of life in the two groups were compared with those in the control group (P > 0.05), the scores of VAS, SDS and SAS decreased significantly, while ESCV, angle of straight leg elevation, ADL, physiological score, emotional score, social score and health status score increased significantly, the difference was statistically significant (P 0.05). Conclusion: Yao Medicine can improve the psychosomatic symptoms of patients with advanced non-small-cell lung carcinoma better, with better efficacy and higher safety. 展开更多
关键词 Yao Medicine non-Small-Cell Lung Carcinoma Advanced Stage EFFICACY Physical and Mental
暂未订购
上一页 1 2 250 下一页 到第
使用帮助 返回顶部